Drooid Logo
Back to story perspectives

Full Breakdown

Spanish Football Association Launches Fertility Support Programme for Women in Football

By Drooid · · How we work

Core Announcement

The Spanish Football Association (RFEF) has unveiled a new programme that will provide fertility treatments—including in-vitro fertilisation (IVF) and egg-freezing—to female players and referees under its jurisdiction. The initiative is presented as a direct response to the reproductive health needs of women working in professional football.

Context of Athlete Support

The move arrives amid growing scrutiny of how sports organisations support female athletes beyond the playing field. Commentators have noted that few governing bodies currently offer systematic access to assisted reproductive technologies for their women’s personnel, prompting comparisons with support structures in other professional sports worldwide.

Expert Perspective

Margie Davenport, a professor of kinesiology and former Canadian synchronized swimmer, highlighted the significance of the RFEF’s decision. She argued that providing IVF and egg-freezing could help address a historically overlooked aspect of women’s health in sport, offering athletes greater control over family planning without compromising their careers. Davenport emphasized that such programmes may set a precedent for other federations to consider similar health-focused benefits.

Anticipated Impact

If fully implemented, the programme could reduce the pressure on female footballers and officials to postpone or forgo family-building decisions due to career demands. By covering the cost of treatments, the RFEF may also alleviate financial barriers that have limited access for many athletes. Observers suggest that the initiative could improve player welfare, potentially influencing recruitment and retention of women in football.

Official Response

The RFEF’s announcement framed the programme as part of a broader commitment to gender-inclusive policies within Spanish football. No further details on eligibility criteria, funding mechanisms, or rollout timelines were provided in the initial statement.